| Zoetis (ZTS) |
United States |
$79.838B |
30.72 |
| Takeda Pharmaceutical (TAK) |
Japan |
$42.573B |
8.86 |
| Sandoz Group AG (SDZNY) |
Switzerland |
$19.533B |
0.00 |
| Merck (MKKGY) |
Germany |
$19.083B |
17.09 |
| Astellas Pharma (ALPMY) |
Japan |
$18.260B |
16.82 |
| United Therapeutics (UTHR) |
United States |
$16.648B |
16.38 |
| Summit Therapeutics (SMMT) |
United States |
$14.012B |
0.00 |
| Neurocrine Biosciences (NBIX) |
United States |
$12.722B |
33.69 |
| Shionogi (SGIOY) |
Japan |
$12.010B |
11.51 |
| Catalent (CTLT) |
United States |
$11.069B |
0.00 |
| Madrigal Pharmaceuticals (MDGL) |
United States |
$7.578B |
0.00 |
| Orion OYJ (ORINY) |
Finland |
$6.653B |
18.71 |
| Corcept Therapeutics (CORT) |
United States |
$6.029B |
45.67 |
| Ionis Pharmaceuticals (IONS) |
United States |
$5.370B |
0.00 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$5.199B |
0.00 |
| PTC Therapeutics (PTCT) |
United States |
$3.334B |
0.00 |
| Dyne Therapeutics (DYN) |
United States |
$3.021B |
0.00 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$2.600B |
15.54 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$2.562B |
11.61 |
| Soleno Therapeutics (SLNO) |
United States |
$2.491B |
0.00 |
| Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$2.247B |
0.00 |
| NewAmsterdam Pharma (NAMS) |
Netherlands |
$1.866B |
0.00 |
| Xencor (XNCR) |
United States |
$1.750B |
0.00 |
| Recursion Pharmaceuticals (RXRX) |
United States |
$1.634B |
0.00 |
| Evotec AG (EVO) |
Germany |
$1.591B |
0.00 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$1.574B |
0.00 |
| Harrow (HROW) |
United States |
$1.528B |
0.00 |
| Indivior (INDV) |
United States |
$1.500B |
6.11 |
| Guardian Pharmacy Services (GRDN) |
United States |
$1.461B |
0.00 |
| Ocular Therapeutix (OCUL) |
United States |
$1.388B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
United States |
$1.361B |
0.00 |
| Cassava Sciences (SAVA) |
United States |
$1.274B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.269B |
0.00 |
| Ardelyx (ARDX) |
United States |
$1.258B |
0.00 |
| Enliven Therapeutics (ELVN) |
United States |
$1.199B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$1.124B |
0.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$0.966B |
5.27 |
| Bioventus (BVS) |
United States |
$0.950B |
30.03 |
| Cronos Group (CRON) |
Canada |
$0.795B |
0.00 |
| Relay Therapeutics (RLAY) |
United States |
$0.795B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$0.760B |
14.10 |
| Oruka Therapeutics (ORKA) |
United States |
$0.726B |
0.00 |
| Elite Pharmaceuticals (ELTP) |
United States |
$0.659B |
0.00 |
| Altimmune (ALT) |
United States |
$0.617B |
0.00 |
| Tourmaline Bio (TRML) |
United States |
$0.590B |
0.00 |
| Savara (SVRA) |
United States |
$0.577B |
0.00 |
| OmniAb (OABI) |
United States |
$0.554B |
0.00 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$0.551B |
0.00 |
| Organogenesis (ORGO) |
United States |
$0.537B |
0.00 |
| Zevra Therapeutics (ZVRA) |
United States |
$0.512B |
0.00 |
| Esperion Therapeutics (ESPR) |
United States |
$0.497B |
0.00 |
| ProKidney (PROK) |
United States |
$0.493B |
0.00 |
| Korro Bio (KRRO) |
United States |
$0.490B |
0.00 |
| Theravance Biopharma (TBPH) |
Cayman Islands |
$0.466B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.463B |
5.40 |
| Xeris Biopharma Holdings (XERS) |
United States |
$0.461B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.459B |
186.00 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.439B |
0.00 |
| Aquestive Therapeutics (AQST) |
United States |
$0.416B |
0.00 |
| Verve Therapeutics (VERV) |
United States |
$0.411B |
0.00 |
| Akebia Therapeutics (AKBA) |
United States |
$0.410B |
0.00 |
| Larimar Therapeutics (LRMR) |
United States |
$0.393B |
0.00 |
| Amylyx Pharmaceuticals (AMLX) |
United States |
$0.361B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
United States |
$0.360B |
0.00 |
| Avita Medical (RCEL) |
United States |
$0.350B |
0.00 |
| Sage Therapeutics (SAGE) |
United States |
$0.316B |
0.00 |
| Nature's Sunshine Products (NATR) |
United States |
$0.296B |
17.58 |
| Aldeyra Therapeutics (ALDX) |
United States |
$0.289B |
0.00 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.271B |
0.00 |
| Lyell Immunopharma (LYEL) |
United States |
$0.265B |
0.00 |
| Lexeo Therapeutics (LXEO) |
United States |
$0.214B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.213B |
0.00 |
| Silence Therapeutics (SLN) |
United Kingdom |
$0.210B |
0.00 |
| Acrivon Therapeutics (ACRV) |
United States |
$0.204B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
United States |
$0.198B |
0.00 |
| Nektar Therapeutics (NKTR) |
United States |
$0.194B |
0.00 |
| Profound Medical (PROF) |
Canada |
$0.186B |
0.00 |
| Nanobiotix S.A (NBTX) |
France |
$0.179B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.178B |
0.00 |
| Galectin Therapeutics (GALT) |
United States |
$0.174B |
0.00 |
| Heron Therapeutics (HRTX) |
United States |
$0.163B |
0.00 |
| Inhibikase Therapeutics (IKT) |
United States |
$0.155B |
0.00 |
| Achieve Life Sciences (ACHV) |
Canada |
$0.148B |
0.00 |
| CytoDyn (CYDY) |
United States |
$0.140B |
0.00 |
| VAXART, INC (VXRT) |
United States |
$0.136B |
0.00 |
| Cardiol Therapeutics (CRDL) |
Canada |
$0.132B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
United States |
$0.126B |
0.00 |
| Pyxis Oncology (PYXS) |
United States |
$0.113B |
0.00 |
| Journey Medical (DERM) |
United States |
$0.112B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
United States |
$0.106B |
0.00 |
| Avalo Therapeutics (AVTX) |
United States |
$0.105B |
0.00 |
| Context Therapeutics (CNTX) |
United States |
$0.104B |
0.00 |
| Century Therapeutics (IPSC) |
United States |
$0.103B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.103B |
0.00 |
| Fractyl Health (GUTS) |
United States |
$0.101B |
0.00 |
| Regulus Therapeutics (RGLS) |
United States |
$0.096B |
0.00 |
| Inotiv (NOTV) |
United States |
$0.093B |
0.00 |
| Assertio Holdings (ASRT) |
United States |
$0.090B |
23.52 |
| Arch Biopartners (ACHFF) |
Canada |
$0.090B |
0.00 |
| Relmada Therapeutics (RLMD) |
United States |
$0.084B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
United States |
$0.083B |
0.00 |
| ESSA Pharma (EPIX) |
Canada |
$0.081B |
0.00 |
| Vivani Medical (VANI) |
United States |
$0.079B |
0.00 |
| CASI Pharmaceuticals (CASI) |
China |
$0.079B |
0.00 |
| Swiftmerge Acquisition (IVCP) |
United States |
$0.076B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.073B |
0.00 |
| OptiNose (OPTN) |
United States |
$0.072B |
0.00 |
| Metagenomi (MGX) |
United States |
$0.071B |
0.00 |
| Scienture Holdings (SCNX) |
United States |
$0.065B |
0.00 |
| AlloVir (ALVR) |
United States |
$0.064B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.062B |
0.00 |
| Mural Oncology (MURA) |
Ireland |
$0.057B |
0.00 |
| Unicycive Therapeutics (UNCY) |
United States |
$0.055B |
0.00 |
| BioVie (BIVI) |
United States |
$0.054B |
0.00 |
| Nutriband (NTRB) |
United States |
$0.053B |
0.00 |
| Prelude Therapeutics (PRLD) |
United States |
$0.052B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.050B |
0.00 |
| Protara Therapeutics (TARA) |
United States |
$0.049B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.047B |
0.00 |
| Gain Therapeutics (GANX) |
United States |
$0.046B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.046B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
United States |
$0.045B |
0.00 |
| VYNE Therapeutics (VYNE) |
United States |
$0.045B |
0.00 |
| FibroGen (FGEN) |
United States |
$0.040B |
0.00 |
| Tempest Therapeutics (TPST) |
United States |
$0.040B |
0.00 |
| Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.038B |
0.00 |
| Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.036B |
0.00 |
| Incannex Healthcare (IXHL) |
Australia |
$0.035B |
0.00 |
| Carisma Therapeutics (CARM) |
United States |
$0.034B |
0.00 |
| CERo Therapeutics Holdings (CERO) |
United States |
$0.033B |
0.00 |
| DURECT (DRRX) |
United States |
$0.031B |
0.00 |
| Surrozen (SRZN) |
United States |
$0.030B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.028B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.028B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.026B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
United States |
$0.024B |
0.00 |
| BioLineRx (BLRX) |
Israel |
$0.022B |
0.00 |
| GlycoMimetics (GLYC) |
United States |
$0.020B |
0.00 |
| Enlivex Therapeutics (ENLV) |
Israel |
$0.020B |
0.00 |
| MEI Pharma (MEIP) |
United States |
$0.019B |
0.00 |
| ProPhase Labs (PRPH) |
United States |
$0.018B |
0.00 |
| Marinus Pharmaceuticals (MRNS) |
United States |
$0.018B |
0.00 |
| Cosmos Health (COSM) |
United States |
$0.017B |
0.00 |
| PolyPid (PYPD) |
Israel |
$0.017B |
0.00 |
| Mannatech (MTEX) |
United States |
$0.016B |
0.00 |
| TherapeuticsMD (TXMD) |
United States |
$0.016B |
0.00 |
| Minerva Neurosciences (NERV) |
United States |
$0.016B |
0.00 |
| Vivos Therapeutics (VVOS) |
United States |
$0.015B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
United States |
$0.015B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.015B |
0.00 |
| Traws Pharma (TRAW) |
United States |
$0.014B |
0.00 |
| NLS Pharmaceutics (NLSP) |
Switzerland |
$0.013B |
0.00 |
| Nuvilex (PMCB) |
United States |
$0.013B |
0.00 |
| Lyra Therapeutics (LYRA) |
United States |
$0.012B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.012B |
0.00 |
| Talphera (TLPH) |
United States |
$0.012B |
0.00 |
| Conduit Pharmaceuticals (CDT) |
United States |
$0.011B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
Israel |
$0.010B |
0.00 |
| Indaptus Therapeutics (INDP) |
United States |
$0.010B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
United States |
$0.010B |
0.00 |
| Dominari Holdings (DOMH) |
United States |
$0.010B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.009B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.008B |
0.00 |
| Klotho Neurosciences (KLTO) |
United States |
$0.007B |
0.00 |
| Plus Therapeutics (PSTV) |
United States |
$0.007B |
0.00 |
| Mangoceuticals (MGRX) |
United States |
$0.007B |
0.00 |
| Ainos (AIMD) |
United States |
$0.006B |
0.00 |
| Viracta Therapeutics (VIRX) |
United States |
$0.006B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.006B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.005B |
0.00 |
| Aditxt (ADTX) |
United States |
$0.005B |
0.00 |
| SHINECO (SISI) |
China |
$0.005B |
0.00 |
| Avenue Therapeutics (ATXI) |
United States |
$0.004B |
0.11 |
| Aptorum Group (APM) |
United Kingdom |
$0.004B |
0.00 |
| Alaunos Therapeutics (TCRT) |
United States |
$0.004B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.004B |
0.00 |
| TNF Pharmaceuticals (TNFA) |
United States |
$0.004B |
0.00 |
| Qualigen Therapeutics (QLGN) |
United States |
$0.004B |
0.00 |
| XORTX Therapeutics (XRTX) |
Canada |
$0.004B |
0.00 |
| Bio-Path Holdings (BPTH) |
United States |
$0.004B |
0.00 |
| Oncternal Therapeutics (ONCT) |
United States |
$0.003B |
0.00 |
| InMed Pharmaceuticals (INM) |
Canada |
$0.003B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.003B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
United States |
$0.003B |
0.00 |
| Heatwurx (PCSA) |
United States |
$0.003B |
0.00 |
| Petros Pharmaceuticals (PTPI) |
United States |
$0.003B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
United States |
$0.003B |
0.00 |
| SciSparc (SPRC) |
Israel |
$0.003B |
0.00 |
| Clearmind Medicine (CMND) |
Canada |
$0.002B |
0.00 |
| Molecular Templates (MTEM) |
United States |
$0.002B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.002B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
United States |
$0.002B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.002B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
China |
$0.002B |
0.00 |
| Altamira Therapeutics (CYTO) |
Bermuda |
$0.001B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
China |
$0.000B |
0.00 |
| PainReform (PRFX) |
Israel |
$0.000B |
0.00 |
| Grifols, S.A (GRFS) |
Spain |
$0.000B |
0.00 |
| 4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
| Procaps Group, S.A (PROC) |
Luxembourg |
$0.000B |
1.77 |
| Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
| Stevanato Group S.p.A (STVN) |
Italy |
$0.000B |
38.53 |
